New York, NY, United States of America

Steven M Larson

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 5.8

ph-index = 6

Forward Citations = 157(Granted Patents)


Location History:

  • Washington, DC (US) (1993 - 2002)
  • New York, NY (US) (2017 - 2024)

Company Filing History:


Years Active: 1993-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Steven M Larson: A Pioneer in Cancer Research

Introduction

Steven M Larson is an esteemed inventor based in New York, NY, renowned for his significant contributions to the field of cancer research. With an impressive portfolio of 18 patents, Larson has developed groundbreaking technologies that focus on advanced therapeutic and diagnostic solutions. His work exemplifies the innovative spirit that drives progress in medical science.

Latest Patents

Amongst his recent patents, two stand out for their potential impact on cancer detection and treatment:

1. **Anti-polysialic acid antibodies and uses thereof**: This patent discusses immunoglobulin-related compositions, including antibodies that can neutralize the activity of polysialic acid. These antibodies hold promise for methods of detecting and treating polysialic acid-associated cancers, providing hope for patients in need.

2. **Multimodal silica-based nanoparticles**: This invention presents a fluorescent silica-based nanoparticle designed for precise disease detection, characterization, and treatment, particularly targeting cancer. With applications spanning various imaging techniques, including PET and MRI, these nanoparticles exhibit enhanced biostability and biocompatibility, reducing toxicity while improving efficacy in vivo.

Career Highlights

Steven M Larson has had an illustrious career, working with prestigious institutions such as the Sloan Kettering Institute for Cancer Research and the Memorial Sloan Kettering Cancer Center. His dedication to advancing cancer research has fostered innovations that resonate within the scientific community and beyond.

Collaborations

Throughout his career, Larson has collaborated with esteemed colleagues such as Jason S Lewis and Michelle S Bradbury. These collaborations have played a vital role in enhancing the scope and impact of his research, enabling significant strides in cancer diagnostics and therapeutics.

Conclusion

Steven M Larson's contributions to the realm of cancer research through his innovative patents and collaborations underscore his status as a leading inventor in this field. His work continues to pave the way for new avenues in the fight against cancer, demonstrating the powerful role of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…